Evolv Technologies ($EVLV) reported approximately 42% revenue growth for the first quarter of 2025, marking an acceleration from 41% in the fourth quarter of 2024 and 37% in the third quarter of 2024. The company is scheduled to hold its earnings call on May 20. Following the report, Evolv's stock price surged by up to 29% on increased trading volume, with call options rising 218% and investors expressing plans to exercise them. Meanwhile, RLX Technology ($RLX) announced its first-quarter 2025 results, posting adjusted earnings per share of $0.028 and revenue of $111.4 million, reflecting a 46.5% year-over-year increase. RLX attributed its growth to strong international expansion and cost optimization despite regulatory challenges in the industry. Other stocks showing gains included SuperCom ($SCPH) and Spry Therapeutics ($SPRY), each up 9%, TGen up 8%, and Rocket Lab ($RKT) up 9%.